Abstract:The prevalence and mortality related to end-stage liver disease (ESLD) continue to rise globally. Liver transplant (LT) recipients continue to be older and have inherently more comorbidities. Among these, cardiac disease is one of the three main causes of morbidity and mortality after LT. Several reasons exist including the high prevalence of associated risk factors, which can also be attributed to the rise in the proportion of patients undergoing LT for metabolic dysfunction-associated steatohepatitis (MASH). Additionally, as people age, the prevalence of now treatable cardiac conditions, including coronary artery disease (CAD), cardiomyopathies, significant valvular heart disease, pulmonary hypertension, and arrhythmias rises, making the need to treat these conditions critical to optimize outcomes. There is an emerging body of literature regarding CAD screening in patients with ESLD, however, there is a paucity of strong evidence to support the guidance regarding the management of cardiac conditions in the pre-LT and perioperative settings. This has resulted in significant variations in assessment strategies and clinical management of cardiac disease in LT candidates between transplant centres, which impacts LT candidacy based on a transplant centre's risk tolerance and comfort level for caring for patients with concomitant cardiac disease. Performing a comprehensive assessment and understanding the potential approaches to the management of ESLD patients with cardiac conditions may increase the acceptance of patients, who appear too complex, but rather require extra evaluation and may be reasonable candidates for LT. The unique physiology of ESLD can profoundly influence preoperative assessment, perioperative management, and outcomes associated with underlying cardiac pathology, and requires a thoughtful multidisciplinary approach. The strategies proposed in this manuscript attempt to review the latest expert experience and opinions and provide guidance to practicing clinicians who assess and treat patients being considered for LT. These topics also highlight the gaps that exist in the comprehensive care of LT patients and the need for future investigations in this field. Liver transplant candidates require a detailed cardiovascular assessment, involving a multidisciplinary approach, which incorporates evaluation of traditional and ESLD factors as well as evaluation for cardiac conditions including coronary artery disease, cardiomyopathies, and rhythm disturbances. Liver disease induces systemic hemodynamic changes including portal hypertension, increased cardiac output, and vascular resistance alterations, predisposing candidates to cardiovascular complications. Thorough cardiovascular evaluation may involve non-invasive tests (electrocardiography, echocardiography, cardiac biomarkers, coronary artery calcium score, stress testing) and invasive assessments (coronary angiography) to stratify risk and guide management decisions. Optimal management should involve lifestyle modifications, pharmacotherapy, revascularization for high-risk patients after discussion with a heart team, review of the immunosuppression regimen, and preoperative optimization. Successful cardiovascular management in liver transplant candidates improves perioperative outcomes and reduces postoperative complications. CNI, calcineurin inhibitor; CSA, cyclosporine; ECG, electrocardiogram; ESLD, end-stage liver disease; MELD, model for end-stage liver disease; MASH, metabolic dysfunction-associated steatohepatitis; Tac, tacrolimus.

CACS, CCTA and mCAD‐LT score in the pre‐transplant assessment of coronary artery disease and the prediction of post‐transplant cardiovascular events

Enhancing pre-transplant cardiac assessment: Validation and utility of the CAD-LT score with CCTA in liver transplant candidates

Visual coronary artery calcium assessment on routine chest CT can readily and cheaply identify liver transplant recipients with a low cardiac risk

Detection of Coronary Artery Disease With Coronary Computed Tomography Angiography and Stress Testing in Candidates for Liver Transplant

Impact of pre-transplant cardiac risk factor burden on post-transplant events in liver transplant recipients

Detection of coronary artery disease in liver transplant recipients: does stress echocardiography still have a role?

Myocardial perfusion imaging is an effective screening test for coronary artery disease in liver transplant candidates

Cardiovascular disease assessment and management in liver transplantation

Clinical and echocardiographic predictors of outcome in liver transplant patients

Prognostic Value of Mitral Annular Calcification in Liver Transplant Patients: Implication in Posttransplant Outcomes

Reduction of Cardiac Allograft Vasculopathy by PCI: Quantification and Correlation With Outcome After Heart Transplantation

Pretransplant Renal Function Evaluated by Serum Cystatin C Was Associated with Mortality after Liver Transplantation: a Single-Center Experience

Cardiac evaluation of the liver transplant candidate

Standardized risk-stratified cardiac assessment and early posttransplant cardiovascular complications in kidney transplant recipients

Evaluation of recipients with significant comorbidity - Patients with cardiovascular disease

Pretransplant cardiac investigations in the Irish renal transplant population--the effectiveness of our current screening techniques in predicting cardiac events

Added prognostic value of visually estimated coronary artery calcium among heart transplant recipients

Cirrhotic Cardiomyopathy Predicts Posttransplant Cardiovascular Disease: Revelations of the New Diagnostic Criteria

Computed tomography pericoronary adipose tissue density predicts coronary allograft vasculopathy and adverse clinical outcomes after cardiac transplantation

Predicting major adverse cardiovascular events after orthotopic liver transplantation using a supervised machine learning model: A cohort study

Integrated Assessment of Coronary Physiology Based on Coronary Angiography in Heart Transplant Patients